| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970791 | The Journal of Heart and Lung Transplantation | 2013 | 6 Pages |
Abstract
Chronic HEV is an important cause of liver test abnormalities after lung transplantation; therefore, routine screening for HEV RNA is strongly recommended in lung transplant recipients. Oral ribavirin appears to be a safe and effective treatment for chronic HEV infection in lung transplant recipients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Annelies MD, PhD, Elisabeth PhD, Hinke Y. MD, Elizabeth B. MD, PhD, Peter MD, PhD, Isabella Bejvl, Hubert G. PhD, Erik A.M. MD, PhD,